Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate—a validated assay for the clinic

The neuraminidase inhibitor oseltamivir (Tamiflu®) is currently the first-line therapy for patients with influenza virus infection. Common analysis of the prodrug and its active metabolite oseltamivircarboxylate is determined via extraction from plasma. Compared with these assays, dried blood spot (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hooff, Gero P., Meesters, Roland J. W., van Kampen, Jeroen J. A., van Huizen, Nick A., Koch, Birgit, Al Hadithy, Asmar F. Y., van Gelder, Teun, Osterhaus, Albert D. M. E., Gruters, Rob A., Luider, Theo M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer-Verlag 2011
Schlagworte:
Original Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3119796/
https://ncbi.nlm.nih.gov/pubmed/21537911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00216-011-5050-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge